13
Views
7
CrossRef citations to date
0
Altmetric
Original Article

Pathogenesis of Cyclosporin A-Induced Autoimmunity: Absence of T-cell Reactivity Towards Syngeneic Antigen Presenting Cells

&
Pages 45-56 | Received 23 Apr 1996, Published online: 07 Jul 2009

References

  • Bos G. M. J., Majoor G D., Willighagen R. G. J, van Breda Vriesman P. J. C. Chronic cyclosporine-induced autoimmune disease in the rat: a new experimental model for scleroderma. J Invest Dermatol 1989; 93: 610–615
  • Glazier A., Tutschka P. J., Farmer E. R., Santos G. W. Graft-versus-host disease in cyclosporin A-treated rats after syngeneic and autologous bone marrow reconstitution. J Exp Med 1983; 158: 1–8
  • Majoor G. D., Wodzig K. W. H., van Breda Vriesman P. J. C. Cyclosporin-induced autoimmunity. Thymus Update, M. D. Kendall, M. A. Ritter. Harwood Acad Press, Chur, Switzerland 1991; 179–200
  • Bos G. M. J., Majoor G. D., van Breda Vriesman P. J. C. Graft-versus-host disease: the need for a new terminology. Immunol Today 1990; 11: 433–436
  • Sakaguchi N., Sakaguchi S. Causes and mechanism of autoimmune disease: cyclosporin A as a probe for the investigation. J Invest Dermatol 1992; 98: 705–765
  • Bonomo A., Kehn P. J., Payer E., Rizzo L., Cheever A. W., Shevach E. M. Pathogenesis of post-thymectomy autoimmunity. Role of syngeneic MLR-reactive T cells. J Immunol 1995; 154: 6602–6611
  • Fowell D., Mason D. Evidence that the T cell repertoire of normal rats contains cells with the potential to cause diabetes. Characterization of the CD4+ T cell subset that inhibits this autoimmune potential. J Exp Med 1993; 177: 627–636
  • Damoiseaux J. G. M. C, Beijleveld L. J. J., van Breda Vriesman P. J. C. Multiple effects of Cyclosporin-A on the thymus in relation to T-cell development and autoimmunity. Clin Immunol Immunopathol 1997; 82: 197–202
  • Hess A. D., Horwitz L., Beschorner W. E., Santos G. W. Development of graft-vs-host diseaselike syndrome in cyclosporine-treated rats after syngeneic bone marrow transplantation. J Exp Med 1985; 161: 718–730
  • Hess A. D., Horwitz L. R., Laulis M. K., Fuchs E. Cyclosporine-induced syngeneic graft-vs-host disease: prevention of autoaggression by treatment with monoclonal antibodies to T lymphocyte cell surface determinants and to MHC class II antigens. Clin Immunol Immunopathol 1993; 69: 341–350
  • Jenkins M. K., Schwartz R. H., Pardoll D. M. Effects of Cyclosporin A on T cell development and clonal deletion. Science 1988; 241: 1655–1658
  • Jones R. S., Hess A. D., Mann R. B., Piantadosi S., Vogelsang G. B., Farmer E. R., Geller R. B., Santos G. W. Induction of graft-versus-host disease after autologous bone marrow transplantation. Lancet 1989; 1: 754–747
  • van Vugt E., Arkema J. M. S., Verdaasdonk M. A. M., Beelen R. H. J., Kamperdijk E. W. A. Morphological and functional characteristics of rat steady state peritoneal dendritic cells. Immunobiol 1991; 184: 14–24
  • Damoiseaux J. G. M. C, Döpp E. A., Verdaasdonk M. A. M., Kamperdijk E. W. A., Dijkstra C. D. Three monoclonal antibodies to antigen presenting cells in the rat with differential influence on cellular interactions. Adv Exp Med Biol 1993; 329: 179–184
  • Pelletier L., Pasquier R., Hirsch F., Sapin C., Druet P. Autoreactive T cells in mercury-induced autoimmune disease: in vitro demonstration. J Immunol 1986; 137: 2548–2554
  • Damoiseaux J. G. M. C., Beijleveld L. J. J., van Breda Vriesman P. J. C. Cutaneous immunopathology of Cyclosporin-A induced autoimmunity in the rat. Clin Immunol Immunopathol 1995; 77: 315–323
  • McMaster W. R., Williams A. F. Identification of la glycoproteins in rat thymus and purification from rat spleen. Eur J Immunol 1979; 9: 426–433
  • Fukumoto T., McMaster W. R., Williams A. F. Mouse monoclonal antibodies against rat major histocompatibility antigens. Two la antigens and expression of la and class I antigens in rat thymus. Eur J Immunol 1982; 12: 237–243
  • Hünig T., Wallny H-J., Hartley J. K., Lawtzky A., Tiefenthaler G. A monoclonal antibody to a constant determinant of the rat T cell antigen receptor that induces T cell activation. J Exp Med 1989; 169: 73–86
  • Cheney R. T., Sprent J. Capacity of cyclospo-rine to induce auto-graft-versus-host disease and impair intrathymic T cell differentiation. Transpl Proc 1985; 17: 528–530
  • Beijleveld L. J. J., Damoiseaux J. G. M. C., van Breda Vriesman P. J. C. The differential effects of X-irradiation and Cyclosporin-A administration on the thymus with respect to the generation of Cyclosporin-A induced Autoimmunity. Dev Immunol 1995; 4: 127–138
  • Damoiseaux J. G. M. C, Beijleveld L. J. J., van Breda Vriesman P. J. C. The effects of in vivo cyclosporin A administration on rat thymic dendritic cells. Clin Exp Immunol 1994; 96: 513–520
  • Beijleveld L. J. J., Damoiseaux J. G. M. C, Roglic M., Theofilopoulos A. N., van Breda Vriesman P. J. C. The lesions of cyclosporine-induced autoimmune disease can be equally well elicited by CD4 or CD8 effector T cells. Transplantation 1996; 62: 1468–1476
  • Bryson J. S., Lake-Bullock H., Pflugh D. L., Jennings C. D., Stuart P. M., Caywood B. E., Kaplan A. M. In vivo reactivity of T cell clones isolated from mice with syngeneic graft-versus-host disease. Transplantation 1995; 60: 171–178
  • Beijleveld L. J. J., Groen H., Broeren C. P. M., Klatter F. A., Kampinga J., Damoiseaux J. G. M. C, van Breda Vriesman P. J. C. Susceptibility to clinically manifest cyclosporine A(CsA)-induced autoimmune disease is associated with Interferon-gamma (IFN-γ) producing CD45RC+RT6-Thelper cells. Clin Exp Immunol 1996; 105: 486–496
  • Elson C. J., Barker R. N., Thompson S. J., Williams N. A. Immunologically ignorant autoreactive T cells, epitope spreading and repertoire limitation. Immunol Today 1995; 16: 71–76
  • Kroemer G. Immunological self-tolerance: an analysis employing cytokines or cytokine receptors encoded by transgenes or a recombinant Viccinia virus. Immunol Rev 1991; 122: 173–204

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.